| Study Comparing Bioavailability of Oral Formulations of Vabicaserin (NCT00541996) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia (NCT00528905) | AstraZeneca | 2007-08-01 |
| A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia (NCT00538070) | Massachusetts General Hospital | 2007-08-01 |
| Complex Problem Solving Training in Schizophrenic Patients (NCT00507988) | Heidelberg University | 2007-08-01 |
| Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients (NCT00501163) | Washington University School of Medicine | 2007-08-01 |
| Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients (NCT01149577) | Central Institute of Psychiatry, Ranchi, India | 2007-08-01 |
| Emotional and Cognitive Abilites of Schizophrenia Patients at Various Time Points (NCT00518999) | Shalvata Mental Health Center | 2007-08-01 |
| A Double Blind Sham Controlled Trial of tDCS in Treating Schizophrenia and Depression (NCT00481026) | Bayside Health | 2007-08-01 |
| Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study (NCT00511277) | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 2007-08-01 |
| Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia (NCT00998608) | Kaohsiung Kai-Suan Psychiatric Hospital | 2007-08-01 |
| Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone (NCT00538642) | The University of Texas Health Science Center at San Antonio | 2007-08-01 |
| Quality of Life (QOL) in Female Patient With Schizophrenia (NCT00498004) | Inje University | 2007-08-01 |
| Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia (NCT01368406) | Federal University of São Paulo | 2007-08-01 |
| An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment (NCT00526877) | Johnson & Johnson Taiwan Ltd | 2007-07-13 |
| A Non-interventional Naturalistic Project to Investigate the Effect of the Use of SMS Text Service on Treatment Adherence in Patients Treated With Seroquel® (Quetiapine) (NCT00533260) | AstraZeneca | 2007-07-01 |
| A Multicenter Study of NAP (AL-108) in Schizophrenia (NCT00505765) | University of California, Los Angeles | 2007-07-01 |
| Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine (NCT00512070) | Seattle Institute for Biomedical and Clinical Research | 2007-07-01 |
| Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits (NCT00487942) | Cephalon | 2007-07-01 |
| Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment (NCT00538122) | Vanderbilt University | 2007-07-01 |
| Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia (NCT01052389) | Mario Negri Institute for Pharmacological Research | 2007-07-01 |
| Schizophrenia Treatment Adherence Investigation (STAI) (NCT01001481) | Janssen-Cilag Pty Ltd | 2007-07-01 |
| Treatment Study for Cognitive Deficits in Schizophrenia (NCT00505076) | University of California, Los Angeles | 2007-07-01 |
| An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia (NCT00566631) | Janssen-Cilag International NV | 2007-07-01 |
| Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder (NCT00457899) | AstraZeneca | 2007-07-01 |
| Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects (NCT00505973) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-07-01 |
| Cognitive Remediation and Functional Skills Training in Schizophrenia (NCT01175642) | National Alliance for Research on Schizophrenia and Depression | 2007-07-01 |
| Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) (NCT00137280) | VA Office of Research and Development | 2007-06-13 |
| Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia (NCT01662648) | Janssen Pharmaceutica | 2007-06-01 |
| Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. (NCT00488319) | Janssen Research & Development, LLC | 2007-06-01 |
| Varenicline Effects In Schizophrenic Smokers (NCT00548470) | Nathan Kline Institute for Psychiatric Research | 2007-06-01 |
| Efficacy of Pregnenolone in Patients With Schizophrenia (NCT00615511) | Weill Medical College of Cornell University | 2007-06-01 |
| Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia (NCT00690365) | AstraZeneca | 2007-06-01 |
| ACP-104 in Acutely Psychotic Subjects With Schizophrenia (NCT00490516) | ACADIA Pharmaceuticals Inc. | 2007-06-01 |
| Anticholinergic Burden in Schizophrenia (NCT00715377) | Centre for Addiction and Mental Health | 2007-06-01 |
| Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight (NCT00584519) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-06-01 |
| Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine (NCT00952757) | Investigaciones Médicas Montejo S.L. | 2007-06-01 |
| Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder (NCT00480571) | BioLineRx, Ltd. | 2007-06-01 |
| Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia (NCT00601224) | University of North Carolina, Chapel Hill | 2007-06-01 |
| Systematic Evaluation of Antiviral Medication in Schizophrenia (NCT00514449) | Konasale Prasad | 2007-06-01 |
| A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets. (NCT00500201) | GlaxoSmithKline | 2007-05-24 |
| Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia (NCT00631722) | Peking University | 2007-05-01 |
| Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis (NCT00465920) | University of Cologne | 2007-05-01 |
| The Compliance Project Concerning People With Schizophrenia (NCT00497848) | Ministry of the Interior and Health, Denmark | 2007-05-01 |
| Donepezil Double Blind Trial for ECT Memory Disfunction (NCT00465283) | BeerYaakov Mental Health Center | 2007-05-01 |
| Varenicline Adjunctive Treatment in Schizophrenia (NCT00492349) | University of Maryland, Baltimore | 2007-05-01 |
| Seroquel Long-Term NIS for Schizophrenia Patients (NCT00523783) | AstraZeneca | 2007-05-01 |
| Health Promotion and Fitness for Younger and Older Adults With SMI (NCT02090335) | Dartmouth-Hitchcock Medical Center | 2007-05-01 |
| Integrated Care in Psychotic Disorders With Severe Mental Illness (NCT01888627) | Universitätsklinikum Hamburg-Eppendorf | 2007-05-01 |
| FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis (NCT00486798) | AstraZeneca | 2007-05-01 |
| An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia (NCT00460512) | Janssen-Cilag International NV | 2007-04-25 |
| Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001) (NCT00725075) | Merck Sharp & Dohme LLC | 2007-04-10 |
| The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia (NCT00488891) | Ortho-McNeil Janssen Scientific Affairs, LLC | 2007-04-01 |
| Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects (NCT00458107) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-04-01 |
| Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients (NCT00396214) | Solvay Pharmaceuticals | 2007-04-01 |
| Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI) (NCT00453609) | State University of New York - Upstate Medical University | 2007-04-01 |
| An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. (NCT00510211) | Eli Lilly and Company | 2007-04-01 |
| Quetiapine and the Dopaminergic Epigenetic Control (NCT00370500) | University of Erlangen-Nürnberg Medical School | 2007-04-01 |
| Efficacy of Selegiline in Negative Symptoms of Schizophrenia (NCT00456976) | Tabriz University | 2007-04-01 |
| An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia (NCT00473434) | Janssen-Cilag Pty Ltd | 2007-04-01 |
| Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward (NCT00418873) | Astellas Pharma Inc | 2007-03-01 |
| Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia (NCT00589914) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-03-01 |
| The Effect of Plasma Osmolality on Brain Glutamate (NCT00611741) | Yale University | 2007-03-01 |
| Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study) (NCT00560677) | Durham VA Medical Center | 2007-03-01 |
| Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia (NCT00590577) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-03-01 |
| Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia (NCT00759460) | H. Lundbeck A/S | 2007-03-01 |
| A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville (NCT00790777) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-03-01 |
| A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR (NCT00791193) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-03-01 |
| Qualitative Analysis on the Experiences of Employment Among Schizophrenic Patients (NCT00423033) | Far Eastern Memorial Hospital | 2007-03-01 |
| Family Study in Schizophrenia (NCT00418912) | Sheba Medical Center | 2007-03-01 |
| Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses (NCT00458094) | Johns Hopkins University | 2007-03-01 |
| Sertindole in Asian Patients With Schizophrenia (NCT00864045) | H. Lundbeck A/S | 2007-03-01 |
| Efficacy of Lu 31-130 in Patients With Schizophrenia (NCT00768326) | H. Lundbeck A/S | 2007-03-01 |
| Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia (NCT00439634) | Sanofi | 2007-02-01 |
| Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia (NCT00407277) | Centre for Addiction and Mental Health | 2007-02-01 |
| Zyprexa and Task Engagement in Schizophrenia (NCT00440843) | VA Connecticut Healthcare System | 2007-02-01 |
| Metabolic Signatures and Biomarkers in Schizophrenia (NCT00466310) | Duke University | 2007-02-01 |
| Cognitive Remediation Therapy (CRT) in Adolescents With EOS (NCT01701609) | Hospital Clinic of Barcelona | 2007-01-01 |
| Effectiveness of Family Group Interventions for People With Schizophrenia (NCT00940394) | The Hong Kong Polytechnic University | 2007-01-01 |
| An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia (NCT01894984) | Xian-Janssen Pharmaceutical Ltd. | 2007-01-01 |
| Effectiveness of Anti-Psychotic in GPs Setting (NCT00543088) | AstraZeneca | 2007-01-01 |
| A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia (NCT01606254) | Janssen Pharmaceutical K.K. | 2007-01-01 |
| Study Evaluating Bifeprunox in Patients With Schizophrenia. (NCT00366327) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone (NCT00644852) | Johnson & Johnson Taiwan Ltd | 2007-01-01 |
| Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia (NCT00492336) | University of Maryland, Baltimore | 2007-01-01 |
| Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With Schizophrenia (NCT00391677) | University of Medicine and Dentistry of New Jersey | 2007-01-01 |
| Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder (NCT00423878) | National Institute of Mental Health (NIMH) | 2007-01-01 |
| Shiatsu Adjuvant Therapy For Schizophrenia (NCT00425399) | Herzog Hospital | 2007-01-01 |
| The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center (NCT00845572) | The University of Texas Health Science Center at San Antonio | 2007-01-01 |
| Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual (NCT00472862) | Neurocom | 2007-01-01 |
| Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia (NCT00797927) | National Taiwan University Hospital | 2007-01-01 |
| Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic (NCT00428350) | AstraZeneca | 2006-12-01 |
| Augmenting Zyprexa With Naltrexone to Ameliorate Metabolic Side-Effects (NCT00567034) | Mclean Hospital | 2006-12-01 |
| An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia (NCT00412620) | Abbott | 2006-12-01 |
| Extract of Ginkgo Biloba and Tardive Dyskinesia (NCT00672373) | Beijing HuiLongGuan Hospital | 2006-12-01 |
| A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients (NCT00392743) | GlaxoSmithKline | 2006-12-01 |
| Recovery Guide Intervention for Recurrent Psychiatric Hospitalization (NCT00400166) | Yale University | 2006-12-01 |
| Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder (NCT00501618) | Manhattan Psychiatric Center | 2006-11-01 |
| Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone (NCT00406315) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-11-01 |
| Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia (NCT00406718) | The University of Texas Health Science Center at San Antonio | 2006-11-01 |
| Open Label Extension Study of Bifeprunox (NCT00366171) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-11-01 |